ID   MDA-MB-231-luc-D3H2LN
AC   CVCL_D257
SY   D3H2LN
DR   Wikidata; Q54904599
RX   PubMed=15987449;
WW   https://web.archive.org/web/20150202002416/http://www.perkinelmer.com/catalog/product/id/119369
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Sequence variation: Heterozygous for BRAF p.Gly464Val (c.1391G>T) (from parent cell line).
CC   Sequence variation: Homozygous for CDKN2A deletion (from parent cell line).
CC   Sequence variation: Heterozygous for KRAS p.Gly13Asp (c.38G>A) (from parent cell line).
CC   Sequence variation: TERT c.228C>T (-124C>T); in promoter (from parent cell line).
CC   Sequence variation: Homozygous for TP53 p.Arg280Lys (c.839G>A) (from parent cell line).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Discontinued: PerkinElmer/Caliper; Catalog number 119369.
CC   Derived from metastatic site: Pleural effusion.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_1D88 ! MDA-MB-231-luc-D3H1
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-07-19; Version: 16
//
RX   PubMed=15987449; DOI=10.1186/bcr1026;
RA   Jenkins D.E., Hornig Y.S., Oei Y.A., Dusich J.M., Purchio T.;
RT   "Bioluminescent human breast cancer cell lines that permit rapid and
RT   sensitive in vivo detection of mammary tumors and multiple metastases
RT   in immune deficient mice.";
RL   Breast Cancer Res. 7:R444-R454(2005).
//